This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Italfarmaco Spa. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Marcello Pezzuto: Innovator in Selective HDAC6 Inhibitors
Introduction
Marcello Pezzuto is a notable inventor based in Paderno Dugnano, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of selective HDAC6 inhibitors. His work focuses on novel compounds that have the potential to impact therapeutic strategies.
Latest Patents
Marcello Pezzuto holds 1 patent for his invention titled "Selective HDAC6 inhibitors." This patent relates to novel benzohydroxamic compounds of formula (I) and (II), along with their pharmaceutically acceptable salts, isomers, and prodrugs. These compounds exhibit a high selective inhibitory activity against the histone deacetylase 6 (HDAC6) enzyme, which is crucial for various biological processes.
Career Highlights
Pezzuto is associated with Italfarmaco Spa, a company known for its commitment to research and development in the pharmaceutical sector. His role at Italfarmaco Spa has allowed him to contribute to innovative solutions in medicine.
Collaborations
Throughout his career, Marcello has collaborated with talented professionals, including Barbara Vergani and Gianluca Caprini. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Marcello Pezzuto's work in developing selective HDAC6 inhibitors showcases his dedication to advancing pharmaceutical science. His contributions are significant in the ongoing quest for effective therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile